You are here

Article info

Article menu

Download PDFPDF

Case Report
Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma

Authors

  • Lea Bottlaender Service de DermatologieImmuCare, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud Pierre-Bénite cedex France Université Claude Bernard Lyon 1 Lyon France PubMed articlesGoogle scholar articles
  • Anne-Laure Breton Service de DermatologieImmuCare, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud Pierre-Bénite cedex France Université Claude Bernard Lyon 1 Lyon France Centre de Recherche en Cancérologie de Lyon Lyon France PubMed articlesGoogle scholar articles
  • Louis de Laforcade Université Claude Bernard Lyon 1 Lyon France Service de NéphrologieHospices Civils de Lyon, Centre Hospitalier Lyon-Sud Pierre-Bénite cedex France PubMed articlesGoogle scholar articles
  • Frederique Dijoud Université Claude Bernard Lyon 1 Lyon France Service d’Anatomie et de Cytologie pathologiqueHospices Civils de Lyon, Groupement Hospitalier Est Bron cedex France PubMed articlesGoogle scholar articles
  • Luc Thomas Service de DermatologieImmuCare, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud Pierre-Bénite cedex France Université Claude Bernard Lyon 1 Lyon France Centre de Recherche en Cancérologie de Lyon Lyon France PubMed articlesGoogle scholar articles
  • Stephane Dalle Service de DermatologieImmuCare, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud Pierre-Bénite cedex France Université Claude Bernard Lyon 1 Lyon France Centre de Recherche en Cancérologie de Lyon Lyon France PubMed articlesGoogle scholar articles

Citation

Bottlaender L, Breton A, de Laforcade L, et al
Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma
Journal for ImmunoTherapy of Cancer 2017;5:57. doi: 10.1186/s40425-017-0261-2
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.